FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

377388009: Erythromycin ethylsuccinate + sulfisoxazole acetyl 200mg/600mg oral suspension (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    2463838017 Erythromycin ethylsuccinate + sulfisoxazole acetyl 200mg/600mg oral suspension (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2469029013 Erythromycin ethylsuccinate + sulphisoxazole acetyl 200mg/600mg oral suspension en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2469508010 Erythromycin ethylsuccinate + sulfisoxazole acetyl 200mg/600mg oral suspension en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Erythromycin ethylsuccinate + sulfisoxazole acetyl 200mg/600mg oral suspension Is a Product containing erythromycin (medicinal product) false Inferred relationship Some
    Erythromycin ethylsuccinate + sulfisoxazole acetyl 200mg/600mg oral suspension Is a Product containing sulfafurazole (medicinal product) false Inferred relationship Some
    Erythromycin ethylsuccinate + sulfisoxazole acetyl 200mg/600mg oral suspension Is a Erythromycin-containing product in oral dose form false Inferred relationship Some
    Erythromycin ethylsuccinate + sulfisoxazole acetyl 200mg/600mg oral suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Erythromycin (substance) false Inferred relationship Some
    Erythromycin ethylsuccinate + sulfisoxazole acetyl 200mg/600mg oral suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Sulfafurazole false Inferred relationship Some
    Erythromycin ethylsuccinate + sulfisoxazole acetyl 200mg/600mg oral suspension Is a Product containing erythromycin ethylsuccinate and sulfafurazole acetyl false Inferred relationship Some
    Erythromycin ethylsuccinate + sulfisoxazole acetyl 200mg/600mg oral suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Sulfafurazole acetyl false Inferred relationship Some
    Erythromycin ethylsuccinate + sulfisoxazole acetyl 200mg/600mg oral suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Erythromycin ethylsuccinate (substance) false Inferred relationship Some
    Erythromycin ethylsuccinate + sulfisoxazole acetyl 200mg/600mg oral suspension Has manufactured dose form Oral suspension false Inferred relationship Some
    Erythromycin ethylsuccinate + sulfisoxazole acetyl 200mg/600mg oral suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Bactericide false Inferred relationship Some
    Erythromycin ethylsuccinate + sulfisoxazole acetyl 200mg/600mg oral suspension Is a Product containing sulfafurazole in oral dose form (medicinal product form) false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start